NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 15, 2005 • Volume 2 / Number 44 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

Updated Results Show Tamoxifen Continues to Prevent Breast Cancer

Updated results from the first-ever, large-scale breast cancer chemoprevention trial show that 5 years of tamoxifen (Nolvadex) decreases the risk of invasive and noninvasive breast cancer among women at increased risk, even after they've stopped taking the drug. According to the study authors, approximately 2.5 million women in the United States are at significant enough breast cancer risk that the potential benefit of prophylactic tamoxifen use significantly outweighs any potential risks.

The findings represent "a beginning from which a new paradigm for breast cancer prevention can evolve," says Dr. Bernard Fisher, principal investigator for the Breast Cancer Prevention Trial (BCPT). "Cohorts of women at increased risk for breast cancer, who could derive a net benefit from receiving tamoxifen, have been clearly defined."

The results may also dispel some perceptions about chemoprevention, says study co-author Dr. Leslie Ford, associate director of NCI's Division of Cancer Prevention.  Read more  

Director's Update

Cancer Center Directors Helping to Chart Path to 2015

Last week, I was in Dallas with the National Cancer Institute's (NCI) senior leadership team to host a retreat of the directors of all NCI-designated Cancer Centers. This was the third such retreat and, as with the first two, its goal was to encourage frank discussions and gain honest input from the directors on some of the most pressing issues facing NCI.

The directors recognize the essential role the Cancer Centers must play if we are to eliminate the suffering and death due to cancer. However, there were concerns among many that the timeline is too ambitious. At the same time, they recognized the substantial opportunities for real progress in the years ahead and were supportive of working with NCI leadership to establish intermediate milestones for reaching the 2015 goal.  Read more  


The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.